From October 1, 2023 to December 31, 2023, the company has repurchased 303,400 shares, representing 0.18% for CNY 3.9 million. With this, the company has completed the repurchase of 724,500 shares, representing 0.42% for CNY 8.97 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.1 CNY | -7.62% | -7.49% | -10.09% |
1st Jan change | Capi. | |
---|---|---|
-10.09% | 332M | |
+20.87% | 8.44B | |
+7.54% | 7.78B | |
+12.95% | 6.77B | |
-4.10% | 3.81B | |
-5.81% | 3.71B | |
+2.08% | 1.4B | |
-27.03% | 1.09B | |
+24.00% | 1.03B | |
-12.15% | 901M |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.